Louis Lehot Authors Article on What’s Next for Seed-Stage and Early-Stage Startups
April 17, 2023
Westlaw
Foley & Lardner LLP Partner Louis Lehot authored the Westlaw Today article, “What’s next for seed-stage and early-stage startups in 2023?” exploring recent challenges facing early-stage startups and strategies for overcoming them.
Lehot examines the historical changes all businesses and industries have faced in the past three years, from the pandemic to inflation and geopolitical turbulence to supply chain disruption. He describes the most significant challenges facing early-stage companies as access to capital, capital burn, regulations and advances in technology, competition for talent, and the overwhelming importance for founders to be prepared to pivot, have patience, and maintain positive, optimistic, and creative energy.
People
Related News
October 9, 2026
In the News
Jonathan Lasken Highlighted Across the Media for Arrival to Foley
Foley & Lardner LLP partner Jonathan Lasken is highlighted across the media for his recent arrival to the firm’s Washington D.C. office.
October 7, 2026
In the News
William Holtz Examines New FDA Approach to Clinical Trial Development
Foley & Lardner LLP of counsel William Holtz is quoted in the PharmaVoice article, “5 Key Facts About the FDA Expedited IND Pilot Program,” examining the FDA's new pilot program and its potential to accelerate clinical research.
October 5, 2026
In the News
Louis Lehot Analyzes U.S. IPO Market Trends and Outlook
Foley & Lardner LLP partner Louis Lehot is featured in the Daily Journal‘s Capital & Counsel newsletter offering insights on the current state of the U.S. IPO market and the factors influencing companies' routes to going public.